Tarsus Pharmaceuticals, Inc. (TARS)

NASDAQ: TARS · Real-Time Price · USD

67.96

-0.21 (-0.31%)

Mar 13, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Therapeutics	451.36M	182.95M	17.45M	25.82M	57.03M
Therapeutics Growth	146.71%	948.62%	-32.42%	-54.73%	-
Total	451.36M	182.95M	17.45M	25.82M	57.03M
Total Growth	146.71%	948.62%	-32.42%	-54.73%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	451.36M	182.95M	17.45M	25.82M	57.03M
United States Growth	146.71%	948.62%	-32.42%	-54.73%	-
Total	451.36M	182.95M	17.45M	25.82M	57.03M
Total Growth	146.71%	948.62%	-32.42%	-54.73%	-

Source: S&P Global Market Intelligence.